`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` UNITED STATES PATENT AND TRADEMARK OFFICE
` ___________________
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
` ___________________
` APPLE INC.
` Petitioner
` V.
` VALENCELL INC.
` Patent Owner
` ___________________
` Case IPR2017-00319
` U.S. Patent No. 8,923,941
` ___________________
`
` ORAL DEPOSITION OF DR. LUCA POLLONINI
` Dallas, Texas
` Thursday, November 9, 2017
`
`Reported by:
`KIM A. McCANN, RMR, CRR, CSR
`JOB NO. 133498
`
`TSG Reporting - Worldwide 877-702-9580
`
`APL1069
`Apple v. Valencell
`IPR2017-00319
`
`
`
`Page 2
`
` DR. LUCA POLLONINI - 11/09/17
` November 9, 2017
` 9:01 a.m.
`
` Oral deposition of DR. LUCA
`POLLONINI, held at the offices of Bragalone
`Conroy, 2200 Ross Avenue, Suite 4500 W, Dallas,
`Texas, pursuant to the Federal Rules of Civil
`Procedure before Kim A. McCann, Registered Merit
`Reporter, Certified Realtime Reporter and
`Certified Shorthand Reporter in and for the State
`of Texas.
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`3
`
`4 5
`
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`Page 3
`
` DR. LUCA POLLONINI - 11/09/17
`A P P E A R A N C E S:
` BRAGALONE CONROY
` BY: JUSTIN KIMBLE, ESQUIRE
` 2200 Ross Avenue
` Dallas, Texas 75201
` Counsel for Valencell, Inc.
`
` STERNE, KESSLER, GOLDSTEIN & FOX
` BY: MICHELLE HOLOUBEK, ESQUIRE
` MARK CONSILVIO, ESQUIRE
` 1100 New York Avenue, NW
` Washington, DC 20005
` Counsel for Apple Inc.
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`3
`4
`5
`6
`7
`
`8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`Page 4
`
` DR. LUCA POLLONINI - 11/09/17
` I N D E X
` PAGE
`Examination By Ms. Holoubek 5
`Examination By Mr. Kimble 178
`
` E X H I B I T S
` (Reference only)
` NUMBER DESCRIPTION PAGE
`Exhibit 1001 U.S. Patent No. 8,923,941 12
`Exhibit 1057 Mault reference article 10
`Exhibit 2006 Copy of IPR2017-00319 8
`Exhibit 2010 Declaration of Luca Pollonini 14
` In Support of Patent Owner
` Response to Petition
` IPR2017-00321
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`3
`4
`5
`
`6 7
`
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`
`
`Page 5
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` P R O C E E D I N G S
` DR. LUCA POLLONINI,
`Having been first duly sworn, testified as
`follows:
` EXAMINATION
`BY MS. HOLOUBEK:
` Q. Good morning.
` A. Good morning.
` Q. Would you please state your full name
`for the record.
` A. Luca Pollonini.
` Q. And you understand you're here today
`to have your deposition taken in connection with
`the testimony you provided in the two inter
`partes review proceedings challenging U.S. Patent
`No. 8,923,941; is that correct?
` A. It is correct.
` Q. Today is it okay with you if I refer
`to the patent at issue at the '941 patent?
` A. Yes, it is.
` Q. And I understand from yesterday's
`proceeding that you have not been deposed prior
`to the deposition yesterday?
` A. Yes.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 6
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` Q. Okay. We'll just revisit a couple of
`ground rules since this is a different
`proceeding. Will you tell me if you do not
`understand my question.
` A. I will.
` Q. And if you do not ask for
`clarification, I will assume that you understood
`my question. Is that okay?
` A. It is okay.
` Q. And as before, we'll take a break
`every 60 to 90 minutes, but if you need to take a
`break before then, just let me know.
` A. I will.
` Q. Okay. And once again, just remember
`that the rules of the patent office require that
`you not discuss the substance of your testimony
`with anyone during the breaks.
` Do you understand?
` A. I do.
` Q. Great. What did you do to prepare
`for today's deposition on the '941 patent?
` A. I reviewed the '941 patent and the
`prior art that is concerned with this matter. I
`also reviewed my own declaration for both IPRs,
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 7
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`and I've also met with Mr. Kimble two days ago
`and also, you know, went over and discussed, you
`know, my declaration in general.
` Q. Other than the patent, prior art, and
`your declaration, did you look at any other
`documents to prepare for today's deposition?
` A. I also re-read roughly very quickly
`also the patent owner response and, yeah, that is
`-- that is the review of the materials I've done.
` Q. Okay. Was Tuesday's meeting with
`Mr. Kimble your only in-person meeting with
`counsel to prepare for today's deposition?
` A. Yes.
` Q. Had you had other meetings either by
`phone or otherwise to prepare for today's
`deposition?
` A. Other than in-phone conversations, we
`just discussed the logistics of this, no.
` Q. Did you meet on the phone or
`otherwise with anyone other than Mr. Kimble?
` A. To prepare for the deposition only?
` Q. Yes.
` A. As far as I remember, I think I only
`discussed matters with Mr. Kimble, yes.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 8
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` Q. Okay. When were you retained for
`your work on the '941 patent IPR?
` A. At the same time that I was retained
`also for the '965 discussed yesterday, mid-July.
` Q. Mid-July of 2017?
` A. 2017, of course.
` Q. Okay. And who contacted you for your
`work on the '941 patent IPR?
` A. Mr. Bill -- William Kennedy with
`Bragalone Conroy.
` Q. Okay. I'm going to go ahead and hand
`you your declarations for this matter. So I just
`handed you what is labeled Exhibit 2006
`IPR2017-00319; is that correct?
` A. Yes, it is correct.
` Q. And can you turn to page 2 of this
`document. And is that your signature on page 2?
` A. Yes, my signature is there.
` Q. And page 2 indicates that this
`document was executed on September 22, 2017.
` Do you see that?
` A. Yes, I do see that.
` Q. And is that an accurate
`representation of the date you signed this
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 9
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`document?
` A. Yes, it is.
` Q. To the best of your knowledge, is
`this document complete and accurate?
` (Witness reviewing document.)
` A. The document is definitely complete.
`There are two corrections that I'd like to make.
` Q. Okay. What are those corrections?
` A. Okay. One I have located is at on
`page 24.
` Q. Okay. Let me just turn there. Okay.
` A. In paragraph 53 --
` Q. Okay.
` A. -- I -- there is an erroneous
`citation. So I'm citing Mault, column 9, lines 9
`to 41.
` Q. Uh-huh.
` A. And actually both -- in the last
`three lines there are two citations to the same
`section of Mault, and I'd like to change this. I
`was just erroneously reporting this. And if I
`may have a copy of Mault, please, just to be
`accurate in this reporting what the right -- I
`have just on top of my head, but I want to make
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 10
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`sure that they're accurate.
` Q. Certainly.
` A. And then locate those for the other
`one.
` Q. Okay. Just real quick, can you
`confirm what I gave you is the Mault reference we
`talked about, Exhibit No. 1057?
` A. Yes, correct. So I'd like to correct
`those two citations. The column number should
`not be column 9 on both occurrences but it's
`rather column 8.
` Q. Okay.
` A. And the section cited instead of
`starting from line 9 actually starts from
`line 11.
` Q. Okay. And does it -- does it go up
`to line 41 of column 8?
` A. The same line, exactly, on both
`occurrences.
` Q. Okay. So the correct citation there
`on both occurrences should be column 8?
` A. 8.
` Q. Lines 11 through 41?
` A. Correct.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 11
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` Q. Okay.
` A. Please give me some time to locate
`the second correction.
` Q. Certainly.
` A. I have located that.
` Q. Okay.
` A. It's on page 37 of my declaration.
` Q. This is the '319 declaration?
` A. Yes, correct, the same declaration.
` Q. Page 37?
` A. Yes.
` Q. Okay.
` A. In my paragraph 86, I am quoting a
`portion of claim 1. I say that "claim 1 requires
`that the physical and physiological activity be
`sensed 'via a signal monitoring device'," and I
`actually misquoted claim 1 of patent '941, which
`I don't have with me.
` Q. I can give you a copy of that.
` A. Thank you so much.
` Q. And just to make sure everything is
`there.
` A. I appreciate that.
` Q. And can you confirm that what I just
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 12
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`handed you is the '941 patent, Exhibit No. 1001?
` A. 1001, that is correct. And the claim
`1 recites in its second paragraph, "sensing a
`physical activity and physiological information
`from a subject via a single monitoring device."
`So I'd like to correct "via a signal monitoring"
`into "single monitoring."
` Q. Okay. So changing the word there
`from "signal" to "single"?
` A. Single, yes, as in claim 1 of
`patent '941.
` Q. Great.
` A. And other than these two corrections,
`then my declaration is complete and accurate.
` Q. Okay. Thank you for those
`clarifications.
` A. Thank you.
` Q. So with those clarifications in mind,
`would you agree that this document contains your
`full testimony regarding claims 1, 2, and 6 to 13
`of the '941 patent?
` A. I apologize. You said 1, 2, and 9
`through 13?
` Q. 6 through 13.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 13
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` A. 6 through 13.
` Q. I might be able to direct your
`attention to page 31 of your declaration.
` A. Oh, thank you so much. I was looking
`at a table and everything else is 6 in there.
`Claim 1 and accordingly claims 2 and 6 through
`13.
` (Witness reading sotto voce.)
` A. Yes.
` Q. Okay. And so you would agree your
`document contains your full testimony on claims 1
`and 6 through 13?
` A. I agree.
` Q. Because we have two declarations, to
`try and distinguish between the two, can I refer
`to the declaration we were speaking of labeled,
`it's labeled as 2006, can I refer to that as the
`'319 declaration referring to the proceedings
`number at the bottom corner?
` A. Yes, you can.
` Q. Let's turn to your other declaration
`that I'm going to hand you.
` A. Thank you.
` Q. So can you confirm that I have handed
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 14
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`you what's labeled as Exhibit 2010 for
`IPR2017-00321?
` A. Yes, I confirm.
` Q. And is this your declaration for the
`patent owner response in the 321 IPR?
` A. Yes, it is.
` Q. Please turn to page 2. Is that your
`signature on page 2?
` A. Yes, it is.
` Q. And is the representation of
`September 22, 2017, an accurate representation of
`when you signed this document?
` A. Yes, it is.
` Q. Okay. Is this document that I've
`handed you accurate and complete?
` A. Yes, it is.
` Q. Okay. Is there anything in this
`document, the '321 declaration, that you would
`like to change?
` A. No.
` Q. Okay. And are you okay if I refer to
`this document as the '321 declaration?
` A. '321 declaration, yes.
` Q. Okay. Thank you. So today I will --
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 15
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`since we're dealing with two declarations, I will
`do my best to call them by their appropriate
`names, either the '319 declaration or the '321
`declaration as is appropriate. Is that okay?
` A. It is okay.
` Q. And if you're -- the question or
`answer doesn't have to do with a specific
`declaration, I'm going to assume that your answer
`applies to the '941 patent as a whole.
` Is that okay?
` A. I understand, yes.
` Q. Have you given any other testimony
`regarding the '941 patent?
` A. No, I have not.
` Q. Okay. Have you prepared any other
`documents that contain your opinions on the '941
`patent?
` A. No, I have not.
` Q. Have you discussed the '941 patent
`with anyone other than the attorneys at
`Bragalone?
` A. No, I have not.
` Q. Did you discuss the '941 patent with
`any attorneys at Warren Rhoades?
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 16
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` A. No, I have not.
` Q. Were you ever provided with a set of
`proposed claim amendments related to the '941
`patent to review?
` A. No.
` Q. Have you provided any testimony or
`opinions that contradict the statements that
`you've made in either the '321 declaration or the
`'319 declaration?
` A. I have not.
` Q. When did you first become aware of
`the '941 patent?
` A. At the time of -- when I was
`contacted by Mr. Kennedy with Bragalone Conroy.
` Q. Okay. And that was mid-July of 2017?
` A. Mid-July, yes.
` Q. And when were you retained as an
`expert to analyze the '941 patent?
` A. Pretty much at the same time.
` Q. Okay. Have you been involved at all
`in the corresponding district court litigation
`involving the '941 patent?
` A. No, I was not involved in that.
` Q. So the only proceeding involving the
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 17
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`'941 patent that you're involved with are these
`IPRs that we're discussing today; is that
`correct?
` A. Correct.
` Q. Are the opinions contained in your
`declaration based on conversations with anyone
`other than the attorneys at Bragalone?
` A. No.
` Q. Okay. Let's start -- well, with the
`-- with the '319 declaration.
` A. Yes.
` Q. When did you draft this declaration?
` A. I started drafting my declaration
`after the initial analysis I did of all the
`materials, of all the relevant materials. So I
`would say around mid-August.
` Q. Okay. And did you draft this
`declaration or did you receive a first draft that
`you then edited?
` A. No. I drafted essentially all the
`declaration, with the exception of the legal
`standard templates that I was, you know,
`provided. I was explained, you know, if I fully
`understood those, and the rest is essentially my
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 18
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`work.
` Q. And who did you work with to draft
`this declaration?
` A. I worked with mostly -- I discussed
`the declaration mostly with Mr. Kimble and with
`Mr. Brian Herrmann with Bragalone Conroy.
` Q. Regarding the '321 declaration, when
`did you begin drafting that declaration?
` A. At the same time I was drafting my
`opinions on the 319.
` Q. Okay. And did you also prepare the
`initial draft of the 321 or did you receive a
`first draft of the '321 declaration from someone
`else?
` A. It was my own -- my own first draft,
`with the exception of the legal standards, which
`are the same -- applies the same to both.
` Q. Okay. And did you also work with
`Mr. Kimble and Mr. Herrmann on drafting the '321
`declaration?
` A. That is correct.
` Q. Did you work with anyone else to
`draft the '321 declaration?
` A. Not that I can remember of.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 19
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` Q. Where you have relied on certain
`materials in your declarations to arrive at your
`opinions, you've provided citations to those
`materials; is that correct?
` A. I did search and I provided materials
`that I thought that were relevant to the
`expression of my opinions, and some of those have
`been, you know, searched and found and provided
`by myself.
` Q. Okay. So regarding your -- strike
`that.
` What is your understanding of
`obviousness?
` MR. KIMBLE: Object to the form.
` You can answer.
` A. So my --
` Q. I can rephrase. What is your
`understanding of the term "obviousness" as it
`applies to your analysis here?
` MR. KIMBLE: Object to the form.
` A. So my -- my understanding as I
`declare here in my document, so I -- the concept
`of obviousness is understood in a claim invention
`-- that a claim invention is not patentable, it
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 20
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`would be obvious to a person of ordinary skill in
`the field of the invention, at the time the
`invention was made. I also understand that the
`obviousness standard is defined the patent
`statute 35 U.S.C. ยง 103(a) as follows:
` (As read) Patent may not be obtained
`through the invention is not identically
`disclosed or described as set forth in
`Section 102 of this title, if the differences
`between the subject matter sought to be patented
`and the prior art are such that the subject
`matter as a whole would have been obvious at the
`time of the invention was made to a person having
`ordinary skill in the art which the subject
`matter pertains. A patent is not invalid because
`of the manner in which the invention was made.
` I also understand that the following
`standards govern the determination of whether a
`claim in a patent is obvious and have applied the
`standards in my evaluation whether claims 1, 2,
`and in this case 6-13 of the '941 patent would
`have been considered obvious.
` I also understand that to find a
`claim in a patent obvious, one must make certain
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 21
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`findings regarding the claimed invention and the
`prior art. Specifically, I understand that the
`obviousness question requires concentration of
`four factors, although not necessarily in the
`following order, which are the scope and the
`content of the prior art, the differences between
`the prior art and the claims at issue, the
`knowledge of a person of ordinary skill in the
`pertinent art, and whatever objective factors
`indicating obviousness or nonobviousness may be
`present in any particular case.
` In addition, I understand that the
`obviousness inquiry should not be done in
`hindsight, but must be done using the perspective
`of a person of ordinary skill in the relevant art
`as -- as of the effective filing date of the
`patent claim.
` I understand that the objective
`factors indicating obviousness or nonobviousness
`may be -- may include the commercial success of
`products covered by the patent claims, a
`long-felt need for the invention, failed attempts
`by others to make the invention, copying of the
`invention by others in the field, unexpected
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 22
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`results achieved by the invention, praise of the
`invention by the infringer or others in the
`field, the taking of licenses under the patent by
`others, expressions of surprise by experts and
`those skilled in the art in the making -- at the
`making of the invention, and the patentee
`proceeded contrary to the accepted wisdom of the
`prior art.
` I understand the combination of
`familiar elements according to known methods is
`likely to be obvious when it does no more than
`yield unpredictable results. I also understand
`that an example of a solution in one field of
`endeavor may make that solution obvious in
`another related field. I also understand that
`market demands or design considerations may
`prompt variations of a prior art system or
`process, either in the same field or a different
`one, and that these variations may be ordinarily
`be considered obvious variations of what have
`been described in the prior art.
` I also understand that if a person of
`ordinary skill can implement a predictable
`variation, that variation would have been
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 23
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`considered obvious. I understand that for
`similar reasons, if a technique has been used to
`improve one device and a person of ordinary skill
`in the art would recognize that it would improve
`similar devices in the same ways using that
`technique to improve, the other device would have
`been obvious unless its actual application yields
`unexpected results or challenges in
`implementation.
` Q. May I interrupt you just briefly?
`Can I confirm that what you have been quoting
`from so far is paragraphs 23 through 30 of your
`'319 declaration?
` A. That is correct, yes.
` Q. And is it safe to say that paragraphs
`31 through 36 also represent your understanding
`of what is required for proper obviousness
`analysis?
` A. Yes, that's a correct assumption.
` Q. Okay. And in the '321 declaration,
`do paragraphs -- are paragraphs 23 through 36 of
`the '321 declaration identical to the same
`paragraphs in the '319 declaration?
` A. I can do a word-by-word comparison,
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 24
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`but I assume they are identical.
` Q. Okay. And so do those paragraphs 23
`through 36 in each declaration represent your
`understanding of what is required for proper
`obviousness analysis?
` A. Yes, it's correct.
` Q. At the time you prepared your
`declaration, were you aware that if an
`obviousness challenge uses two references in
`combination, that the combination must be
`addressed, not just the references separately?
` A. Sorry. Can you repeat the question
`again for me?
` Q. Sure.
` A. Thank you.
` Q. At the time you prepared your
`declaration, were you aware that when an
`obviousness challenge uses two references in
`combination, that it is the combination that must
`be addressed?
` MR. KIMBLE: Object to the form.
` A. Yes.
` Q. And were you aware that it's not
`sufficient to address those references separately
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 25
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`rather than the combination?
` MR. KIMBLE: Object to the form.
` A. So when I -- when I address
`obviousness, of course, I -- in my analysis tried
`to fully understand what both pieces of the art
`teach independently and also in combination with
`each other.
` Q. Is it your understanding that there
`must be some motivation in the base reference
`that would cause a person of skill in the art to
`combine the base reference with a second
`reference?
` MR. KIMBLE: Object to the form.
` A. My understanding is that if a person
`reads one analysis -- one piece of the art, there
`has to be a specific desire or has to identify a
`specific problem that presumably another piece of
`the art, you know, could potentially teach, and
`if there is a lack of a problem of a multi
`vision, then one person of ordinary skill in the
`art would not seek to solve that problem with --
`by looking elsewhere.
` Q. When you refer to a specific problem,
`is that a specific problem identified by the
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 26
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`reference?
` A. By the reference, you mean --
` Q. By the first reference that you're
`looking at.
` A. By the first reference?
` Q. Yes.
` A. It could be a problem that a person
`of, you know, skill in the art would, you know,
`come up by himself, but it's mostly, you know,
`driven by maybe a flaw or a missing maybe piece
`of information or a desire that is already --
`that is mentioned already in the specification of
`the base reference.
` Q. Okay. Turning to the '319
`declaration first. In 38 through 44 you
`provided --
` A. Excuse me. Can you repeat the
`paragraphs?
` Q. Certainly. Paragraphs 38 through 44.
` A. 38 -- yes, in these paragraphs, I
`provide a general overview of the patent.
` Q. Okay. And in paragraphs 38 and 39 in
`particular, you provided several purposes for the
`invention described in the '941 patent; is that
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 27
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`correct?
` (Witness reviewing document.)
` A. Yes, it describes general needs in
`the -- in the realm discussing in the '941 patent
`at the time of the invention, yes.
` Q. Okay. And as an example, in
`paragraph 38, you quote the '941 patent in
`indicating "a growing market demand for personal
`health and environmental monitors," and further
`in that paragraph, a "growing interest generating
`and comparing health and environmental exposure
`statistics of the general public and particular
`demographic groups." Is that correct?
` A. Yes, those are citations from '941.
` Q. Okay. So when speaking of generating
`and comparing health and environmental exposure
`statistics of the general public and particular
`demographic groups, do you understand that to
`involve looking at data from monitoring devices
`of different subjects?
` A. Can you please repeat your question
`again?
` Q. Sure. Referring to the quotation
`that you have regarding generating and comparing
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 28
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`health and environmental exposure statistics of
`the general public and particular demographic
`groups, do you understand that to involve looking
`at data from monitoring devices of different
`subjects?
` A. I don't intend that to be comparison
`across subjects. So, of course, this monitoring
`devices can be worn by a variety of people for
`different -- for different reasons, which might
`be different from -- from each other. When I --
`when it says, you know, comparing data is a very
`generic term that -- or at least my understanding
`of this term is pretty generic. It can be to
`understand differences amongst different
`populations, but it can be a comparison so to
`speak against, like, some person. So how they --
`like how a person, you know -- how the health or
`environmental information about one specific
`individual changes over time. So it's a
`comparison across time rather than across people.
` So this comparison is just part of
`the data analysis and it can be interpreted very
`generally.
` Q. Okay. So when the patent refers to
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 29
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`comparing statistics of the general public, it's
`your position that that means looking at the
`statistics of a single person?
` A. Not only of a single -- it can be a
`single individual, it can be multiple
`individuals, multiple populations with different
`characteristics.
` Q. When it says comparing statistics of
`particular demographic groups, is it your
`position that that is just looking at statistics
`of one person?
` A. No, not necessarily. It can be an
`individual, it can be multiple -- multiple
`individuals.
` Q. Okay. Can you explain how
`photoplethysmography works?
` (Discussion off the record.)
` A. So photoplethysmography is spelled
`P-h-o-t-o-p-l-e-t-h-y-s-m-o-g-r-a-p-h-y.
` Q. And can we agree that PPG is an
`acceptable acronym for photoplethysmography?
` A. Yes, we can. I guess one -- or a
`description of a PPG sensor in this case is the
`one that I've given in my declaration in
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 30
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`paragraph 72. So --
` Q. And this is of the '319 declaration?
` A. Of the '319 declaration, yes. So a
`PPG sensor is an optical sensor which contains a
`plethysmograph that results from blood flow
`modulation caused by the subject's heartbeat.
` Q. So I understand that is your
`definition of a PPG sensor.
` A. Yes.
` Q. Can you explain how PPG works?
` A. So a PPG is in -- so PPG we refer to
`photoplethysmography is essentially an optical
`technique that seeks to measure the variations
`over time or to detect actually the blood volume
`in -- in a subject with -- with an optical
`methodology.
` Q. So a PPG sensor uses an optical
`detector to measure light; is that correct?
` A. Yes, it requires -- it's one
`requirement is an optical detector that measures
`light.
` Q. And the raw signal that it receives
`is the light intensity; is that correct?
` A. It is the light intensity or power.
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 31
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
` Q. And then the optical detector
`converts that light intensity signal from the
`optical signal into an electrical signal; is that
`correct?
` A. Yes.
` Q. And based on that electrical signal,
`a processor then determines physiological
`perimeters such as heart rate; is that correct?
` A. It is one of the parameters that
`could be extracted from a PPG signal.
` Q. And another parameter that could be
`extracted from a PPG signal is respiration rate?
` A. In the case of the '941 patent, it
`discloses a method that, you know, seeks to
`extract those respiration rate from a PPG.
` Q. In general, can a PPG sensor signal
`be used to determine respiration rate?
` A. What do you mean by in general?
` Q. So do PPG sensors other than the one
`disclosed in the '941 patent also calculate a
`respiration rate from the sensor signal?
` A. I would say that somebody, of course,
`needs to be, you know, knowledgeable about how to
`do it. There are certain I would say
`
`TSG Reporting - Worldwide 877-702-9580
`
`
`
`Page 32
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` DR. LUCA POLLONINI - 11/09/17
`requirements or, you know, experimental
`conditions that need to be met in order to
`successfully extract a respiration rate. But it
`is -- it is possible to extract a respiration
`rate from a -- from a PPG signal alone.
` Q. What are some of those experimental
`conditions that need to be met to successfully
`extract a respiration rate from PPG sensors?
` A. So one of them,